Literature DB >> 30603243

Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance.

Kazuhiko Sakaguchi1, Kazuo Takeda2, Mitsuo Maeda3, Wataru Ogawa1, Toshiyuki Sato4, Seiki Okada4, Yasuhito Ohnishi4, Hiromu Nakajima5, Atsunori Kashiwagi6.   

Abstract

HbA1c and fasting plasma glucose (FPG) levels are commonly recognized as diagnostic indices for diabetes and glucose intolerance. However, they are not sufficient for clear detection of glucose intolerance in the early stage unless an oral glucose tolerance test (OGTT) is performed. Moreover, even in case of an OGTT, 2-h postprandial plasma glucose (PG) levels, a criterion for glucose intolerance in OGTTs, may not provide complete information regarding glucose tolerance. Whole glucose excursion after OGTT is considered to represent glucose tolerance well, and the glucose area under the curve (AUC) can be an index of glucose excursion. However, few studies have investigated measurement of the glucose AUC in glucose intolerance screening. In the present study, data from 520 OGTTs were analyzed to define the cutoff value for the glucose AUC for glucose intolerance screening. Our results showed that a cutoff value of 290 mg h/dl for the glucose AUC was highly sensitive and specific (90 and 93 %, respectively) for detecting diabetes, impaired glucose tolerance (IGT), and group at increased risk of diabetes (normal glucose tolerance with 1-h PG levels of ≥180 mg/dl after glucose load) and showed a better concordance rate than the use of HbA1c, FPG, or 2-h PG levels. Moreover, the cutoff value for the glucose AUC calculated using the diagnostic criteria in the OGTT (305 mg h/dl) was consistent with the value determined from OGTT analysis. These data suggest a possibility that glucose intolerance screening using a glucose AUC cutoff value of 290 mg h/dl could be useful.

Entities:  

Keywords:  Glucose area under the curve; Glucose intolerance; Oral glucose tolerance test; Screening

Year:  2015        PMID: 30603243      PMCID: PMC6214468          DOI: 10.1007/s13340-015-0212-4

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  19 in total

1.  An integrated wearable microneedle array for the continuous monitoring of multiple biomarkers in interstitial fluid.

Authors:  Farshad Tehrani; Hazhir Teymourian; Brian Wuerstle; Jonathan Kavner; Ravi Patel; Allison Furmidge; Reza Aghavali; Hamed Hosseini-Toudeshki; Christopher Brown; Fangyu Zhang; Kuldeep Mahato; Zhengxing Li; Abbas Barfidokht; Lu Yin; Paul Warren; Nickey Huang; Zina Patel; Patrick P Mercier; Joseph Wang
Journal:  Nat Biomed Eng       Date:  2022-05-09       Impact factor: 25.671

2.  Mechanism of protection from insulin resistance by toll-like receptor 2 deficiency in high-fat diet fed mice: involvement in macrophage polarization.

Authors:  Yu Ma; Xinyue Liu; Yaliu Wu; Wendong Wang; Xiaotong Chang
Journal:  Mol Biol Rep       Date:  2022-01-16       Impact factor: 2.316

3.  Patterns of changes in fasting plasma glucose, hemoglobin A1c and the area under the curve during oral glucose tolerance tests in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.

Authors:  Shahla Safari; Masoud Amini; Ashraf Aminorroaya; Awat Feizi
Journal:  Acta Diabetol       Date:  2020-10-21       Impact factor: 4.280

4.  Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany.

Authors:  Anette-Gabriele Ziegler; Kerstin Kick; Ezio Bonifacio; Florian Haupt; Markus Hippich; Desiree Dunstheimer; Martin Lang; Otto Laub; Katharina Warncke; Karin Lange; Robin Assfalg; Manja Jolink; Christiane Winkler; Peter Achenbach
Journal:  JAMA       Date:  2020-01-28       Impact factor: 56.272

5.  Quercetin ameliorates diabetic encephalopathy through SIRT1/ER stress pathway in db/db mice.

Authors:  Tian Hu; Jing-Jing Shi; Jiansong Fang; Qi Wang; Yun-Bo Chen; Shi-Jie Zhang
Journal:  Aging (Albany NY)       Date:  2020-04-20       Impact factor: 5.682

6.  The Impact of an Early Lifestyle Intervention on Pregnancy Outcomes in a Cohort of Insulin-Resistant Overweight and Obese Women.

Authors:  Daniela Menichini; Elisabetta Petrella; Vincenza Dipace; Alessia Di Monte; Isabella Neri; Fabio Facchinetti
Journal:  Nutrients       Date:  2020-05-21       Impact factor: 5.717

7.  Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice.

Authors:  Tian Hu; Xin-Yi Lu; Jing-Jing Shi; Xiao-Qi Liu; Qu-Bo Chen; Qi Wang; Yun-Bo Chen; Shi-Jie Zhang
Journal:  J Cell Mol Med       Date:  2020-01-30       Impact factor: 5.310

8.  Serum angiopoietin-like 3 levels are elevated in obese non diabetic men but are unaffected during an oral glucose tolerance test.

Authors:  Maria Fernanda Garcés; Julieth Daniela Buell-Acosta; Haiver Antonio Rodríguez-Navarro; Estefania Pulido-Sánchez; Juan José Rincon-Ramírez; Diana Carolina Moreno-Ordóñez; Roberto Franco-Vega; Jhoan Sebastian Roncancio-Muñoz; Alvaro Javier Burgos-Cardenas; Ezequiel Lacunza; Justo P Castaño; Carlos Diéguez; Rubén Nogueiras; Elizabeth Sanchez; Jorge Eduardo Caminos
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

9.  Carbohydrate supplementation and psychophysiological responses during moderate exercise in hypoxia.

Authors:  E Tavares-Silva; F F Donatto; R M V Medeiros; S A Santos; A V Caris; R V Thomatieli-Santos
Journal:  J Int Soc Sports Nutr       Date:  2020-01-06       Impact factor: 5.150

10.  Metabolic Effects of Selective Deletion of Group VIA Phospholipase A2 from Macrophages or Pancreatic Islet Beta-Cells.

Authors:  John Turk; Haowei Song; Mary Wohltmann; Cheryl Frankfater; Xiaoyong Lei; Sasanka Ramanadham
Journal:  Biomolecules       Date:  2020-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.